Cargando…
Antithrombin lowering in hemophilia: a closer look at fitusiran
Thrombin is a key enzyme in the maintenance of normal hemostatic function and is the central product of an interconnected set of simultaneously occurring cellular and proteolytic events. Antithrombin (AT) is a natural anticoagulant that downregulates different components of the clotting process, par...
Autores principales: | Young, Guy, Lenting, Peter J., Croteau, Stacy E., Nolan, Beatrice, Srivastava, Alok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285540/ https://www.ncbi.nlm.nih.gov/pubmed/37358958 http://dx.doi.org/10.1016/j.rpth.2023.100179 |
Ejemplares similares
-
Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort
por: Pasi, K. John, et al.
Publicado: (2021) -
S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX
por: Kenet, Gili, et al.
Publicado: (2023) -
An investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B
por: Machin, Nicoletta, et al.
Publicado: (2018) -
Antithrombin inhibition using nanobodies to correct bleeding in hemophilia
por: O'Sullivan, Jamie M, et al.
Publicado: (2020) -
Proteinuria—take a closer look!
por: Bökenkamp, Arend
Publicado: (2020)